Depot formulations
Pharmaceutical compositions comprising an active pharmaceutical ingredient, a high viscosity liquid carrier material, a hydrophobic solvent, and a hydrophilic solvent are disclosed. Also disclosed are methods of manufacturing and using the compositions. The compositions are suitable for use, e.g., as depot formulations.
1. A composition comprising:
sirolimus present in an amount ranging from about 1 wt % to about 5 wt %, based on weight of the composition;
sucrose acetate isobutyrate (SAIB) present in an amount ranging from about 0.5 wt % to about 5 wt %, based on weight of the composition;
benzyl benzoate present in an amount ranging from about 35 wt % to about 50 wt %, based on weight of the composition;
ethanol present in an amount ranging from about 1 wt % to about 10 wt %, based on weight of the composition;
polyethylene glycol (PEG) present in an amount ranging from about 40 wt % to about 50 wt %, based on weight of the composition; and
vitamin E in an amount ranging from about 0.01 wt % to about 5 wt % wherein when the composition is administered intra-ocularly as a single dose to a rabbit, a median amount of sirolimus released from the composition at 6 months after administration ranges from 30% to 100% of a total amount of the sirolimus in the composition at the time of administration.
2. The composition of claim 1 , wherein
the vitamin E is present in an amount ranging from about 0.5 wt % to about 2 wt %, based on weight of the composition.
3. The composition of claim 1 , wherein the benzyl benzoate is present in an amount ranging from about 35 wt % to about 45 wt %, based on weight of the composition.
4. The composition of claim 1 , wherein the composition has a weight ratio of SAIB:vitamin E ranging from about 0.5 to about 10.
5. The composition of claim 1 , wherein the benzyl benzoate is present in an amount ranging from about 40 wt % to about 50 wt %, based on weight of the composition.
6. The composition of claim 1 , wherein the ethanol is present in an amount ranging from about 1 wt % to about 7 wt %, based on weight of the composition.
7. The composition of claim 1 , wherein the ethanol is present in an amount ranging from about 3 wt % to about 10 wt %, based on weight of the composition.
8. The composition of claim 1 , wherein at least 98% of the sirolimus in the composition remains after storage in a 2 mL crimp sealed glass vial for 18 weeks at 5° C./60% RH.
9. The composition of claim 1 , wherein at least 90% of the sirolimus in the composition remains after storage in a 2 mL crimp sealed glass vial for 18 weeks at 25° C./60% RH.
10. The composition of claim 1 , wherein a weight ratio of SAIB to vitamin E ranges from about 60:1 to about 1:2.
11. The composition of claim 1 , wherein a weight ratio of SAIB to vitamin E ranges from about 10:1 to about 1:1.8.
12. The composition of claim 1 , wherein a weight ratio of SAIB to vitamin E ranges from about 5:1 to about 1:1.5.
13. The composition of claim 1 , wherein a weight ratio of SAIB to vitamin E ranges from about 2:1 to about 1:1.5.
14. The composition of claim 1 , wherein the composition has a density at 25° C. and 1 atmosphere ranging from 1.02 g/mL to 1.15 g/mL.
15. The composition of claim 1 , wherein the composition has a viscosity ranging from about 1 cP to about 150 cP at 25° C. and 1 atmosphere.
16. The composition of claim 1 , wherein the composition has a viscosity ranging from about 5 cP to about 50 cP at 25° C. and 1 atmosphere.
17. The composition of claim 1 , wherein the composition has a viscosity ranging from about 10 cP to about 30 cP at 25° C. and 1 atmosphere.
18. The composition of claim 1 , wherein the vitamin E is present in an amount ranging from about 0.1 wt % to about 5 wt %, based on weight of the composition.
19. The composition of claim 1 , wherein the vitamin E is present in an amount ranging from about 0.02 wt % to about 0.09 wt %, based on weight of the composition.